1. Comprehensive and up-to-date information will be provided on guidance and standards of organisation, processes, quality assurance, and data collection management in LDCT lung cancer screening programmes; state-of-play in LDCT lung cancer screening within EU MS and outside the EU; LDCT implementation barriers in EU Member States, and on-going and future scientific developments and unmet research needs.
2. Synergies and complementarity will be ensured through contributions to and interactions with leaders and members of WP and tasks and working groups, Health Authorities and other stakeholders with EU Member States and other related EU Projects.
3. Advising on standardisation of cancer screening programmes and quality assurance and data collection across the 6 established cancer entities covered within this JA Consortium and future screening programmes in other cancer
entities.
4. Consult and help to facilitate the planning, set-up, and performance of pilots and programmes aiming at implementation and improvement of LDCT lung cancer screening and data collection projects within this JA Consortium and at the levels of EU and its MS. Task 8.1 will build upon the substantial expertise and experience and results and outputs of the EU4Health Consortium SOLACE on the implementation of LDCT lung cancer screening, amongst others European a Lung Cancer Screening Guideline with comprehensive Quality Assurance and Data Parameter Set, State-of-Play and related Gap Analyses within EU Member and EAA States, Findings from Implementation Projects, and Educational Formats. The link to SOLACE will be achieved via their open-access Knowledge Hub.
This task will be led by MSB, Germany, co-led by NKIP, Hungary.